The patents cover FHJ Scientific’s proprietary SHBAN compound solution. Scientific evidence and studies by top medical institutions suggest the unique solution may be used in a variety of ways such as aiding the healing of gingivitis or gum disease, wound healing, antiseptic nasal spray, sunburn and burn healing, psoriasis, fungal infections such as athletes foot, eye infections and cuts or abrasions.
BioTech Medics (BTMD) intends to soon announce the addition of a new advisory board member to assist in making application for medical research grants for further development of the SHBAN compound solution.
“The asset acquisition is a major accomplishment for BTMD and part of our long-term planning. BTMD was able to acquire the patents, which have over 15 years of R&D, for stock in BTMD,” said Keith Houser, the company’s CEO.